Real-time enrollment status for this al amyloidosis clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:25 AM UTC
| NCT Number | NCT06158854 |
| Recruiting Status | Recruiting |
| Condition | AL Amyloidosis |
| Phase | Clinical Trial |
| Target Enrollment | 76 participants |
| Active Locations | 10 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | December 17, 2025 (Dec 17, 2025) |
As of March 2, 2026: Clinical trial NCT06158854 is currently recruiting participants. This clinical trial study for al amyloidosis is actively seeking new participants at 10 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06158854 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06158854 was last updated Dec 17, 2025 (December 17, 2025). HelloStudys verifies this status automatically.